Flow cytometry in peripheral blood reticulocytes as a marker of chromosome instability in highgrade glioma patients

Lina Marcela Barrera, León Darío Ortiz, Hugo Grisales, Mauricio Rojas, Mauricio Camargo, .

Keywords: Flow cytometry, reticulocytes, chromosome instability, glioma, micronucleus tests

Abstract

Introduction: The quantification of chromosomal instability is an important parameter to assess genotoxicity and radiosensitivity. Most conventional techniques require cell cultures or laborious microscopic analyses of chromosomes or nuclei. However, a flow cytometry that selects the reticulocytes has been developed as an alternative for in vivo studies, which expedites the analytical procedures and increases up to 20 times the number of target cells to be analyzed.
Objectives: To standardize the flow cytometry parameters for selecting and quantifying the micronucleated reticulocytesCD71+ (MN-RET) from freshly drawn peripheral blood and to quantify the frequency of this abnormal cell subpopulation as a measure of cytogenetic instability in populations of healthy volunteers (n =25), and patients (n=25), recently diagnosed with high-grade gliomas before the onset of treatment.
Materials and methods: Blood cells were methanol-fixed and labeled with anti-CD-71-PE for reticulocytes, antiCD-61-FITC for platelet exclusion, and propidium iodide for DNA detection in reticulocytes. The MN-RETCD71+ cell fraction was selected and quantified with an automatic flow cytometer.
Results: The standardization of cytometry parameters was described in detail, emphasizing the selection and quantification of the MN-RETCD71+ cellular fraction. The micronuclei basal level was established in healthy controls. In patients, a 5.2-fold increase before the onset of treatment was observed (p <0.05).
Conclusion: The data showed the usefulness of flow cytometry coupled with anti-CD-71-PE and anti-CD-61-FITC labeling in circulating reticulocytes as an efficient and high resolution method to quantify chromosome instability in vivo. Finally, possible reasons for the higher average of micronuclei in RETCD71+ cells from untreated high-grade glioma patients were discussed.

Downloads

Download data is not yet available.
  • Lina Marcela Barrera Grupo de Genética, Regeneración y Cáncer (GRC), Instituto de Biología, Universidad de Antioquia, Medellín, Colombia
  • León Darío Ortiz Grupo de Genética, Regeneración y Cáncer (GRC), Instituto de Biología, Universidad de Antioquia, Medellín, Colombia Instituto de Cancerología-Clínica Las Américas, Medellín, Colombia
  • Hugo Grisales Grupo de Investigación Demografía y Salud, Facultad Nacional de Salud Pública, Universidad de Antioquia, Medellín, Colombia
  • Mauricio Rojas Unidad de Citometría de Flujo y Grupo de Inmunología Celular e Inmunogenética (GICIG), Facultad de Medicina, Universidad de Antioquia, Medellín, Colombia
  • Mauricio Camargo Grupo de Genética, Regeneración y Cáncer (GRC), Instituto de Biología, Universidad de Antioquia, Medellín, Colombia

References

Fenech M, Holland N, Chang WP, Zeiger E, Bonassi S. The Human MicroNucleus Project—An international collaborative study on the use of the micronucleus technique for measuring DNA damage in humans. Mutat Res. 1999;428:271-83. https://doi.org/10.1016/S1383-5742(99)00053-8

Bonassi S, Znaor A, Ceppi M, Lando C, Chang WP, Holland N, et al. An increased micronucleus frequency in peripheral blood lymphocytes predicts the risk of cancer in humans. Carcinogenesis. 2007;28:625-31. https://doi.org/10.1093/carcin/bgl177

Dertinger SD, Miller RK, Brewer K, Smudzin T, Torous DK, Roberts DJ, et al. Automated human blood micronucleated reticulocyte measurements for rapid assessment of chromosomal damage. Mutat Res. 2007;626:111-9. https://doi.org/10.1016/j.mrgentox.2006.09.003

Araldi RP, de Melo TC, Mendes TB, de Sá Júnior P, Nozima BH, Ito ET, et al. Using the comet and micronucleus assays for genotoxicity studies: A review. Biomed Pharmacother. 2015;72:74-82. https://doi.org/10.1016/j.biopha.2015.04.004

Fenech M, Kirsch-Volders M, Natarajan AT, Surralles J, Crott JW, Parry J, et al. Molecular mechanisms of micronucleus, nucleoplasmic bridge and nuclear bud formation in mammalian and human cells. Mutagenesis. 2011;26:125-32. http://dx.doi.org/10.1093/mutage/geq052

Balmus G, Karp NA, Ng BL, Jackson SP, Adams DJ, McIntyre RE. A high-throughput in vivo micronucleus assay for genome instability screening in mice. Nat Protoc. 2014;1:205-15. https://doi.org/10.1038/nprot.2015.010

Hanahan D, Weinberg RA. Hallmarks of cancer: The next generation. Cell. 2011;144:646-74. https://doi.org/10.1016/j.cell.2011.02.013

von Ledebur M, Schmid W. The micronucleus test. Methodological aspects. Mutat Res. 1973;19:109-17. https://doi.org/10.1016/0027-5107(73)90118-8

Schmid W. The micronucleus test. Mutat Res. 1975;31:9-15. https://doi.org/10.1016/0165-1161(75)90058-8

Chen Y, Tsai Y, Nowak I, Wang N, Hyrien O, Wilkins R, et al. Validating high-throughput micronucleus analysis of peripheral reticulocytes for radiation biodosimetry: Benchmark against dicentric and CBMN assays in a mouse model. Health Phys. 2010;98:218-27. https://doi.org/10.1097/HP.0b013e3181abaae5

Dertinger SD, Torous DK, Hayashi M, MacGregor JT. Flow cytometric scoring of micronucleated erythrocytes: An efficient platform for assessing in vivo cytogenetic damage. Mutagenesis. 2011;26:139-45. https://doi.org/10.1093/mutage/geq055

Dertinger SD, Torous DK, Hall NE, Murante FG, Gleason AE, Miller RK, et al. Enumeration of micronucleated CD71-positive human reticulocytes with a single-laser flow cytometer. Mutat Res. 2002;515:3-14. https://doi.org/10.1016/S1383-5718(02)00009-8

Dertinger SD, Chen Y, Miller RK, Brewer K, Smudzin T, Torous DK, et al. Micronucleated CD71-positive reticulocytes: A blood-based endpoint of cytogenetic damage in humans. Mutat Res. 2003;542:77-87. https://doi.org/10.1016/j.mrgentox.2003.08.004

Torous DK, Dertinger SD, Hall NE, Tometsko CR. Enumeration of micronucleated reticulocytes in rat peripheral blood: A flow cytometric study. Mutat Res. 2000;465:91-9. https://doi.org/10.1016/S1383-5718(99)00216-8

Bonassi S, Fenech M, Lando C, Lin YP, Ceppi M, Chang WP, et al. HUman MicroNucleus project: International database comparison for results with the cytokinesis-block micronucleus assay in human lymphocytes: I. Effect of laboratory protocol, scoring criteria, and host factors on the frequency of micronuclei. Environ Mol Mutagen. 2001;37:31-45. https://doi.org/10.1002/1098-2280(2001)37:1<31::AIDEM1004>3.0.CO;2-P

Chang P, Li Y, Li D. Micronuclei levels in peripheral blood lymphocytes as a potential biomarker for pancreatic cancer risk. Carcinogenesis. 2010;32:210-5. https://doi.org/10.1093/carcin/bgq247

Cao J, Liu Y, Sun H, Cheng G, Pang X, Zhou Z. Chromosomal aberrations, DNA strand breaks and gene mutations in nasopharyngeal cancer patients undergoing radiation therapy. Mutat Res. 2002;504:85-90. https://doi.org/10.1016/S0027-5107(02)00082-9

Berg-Drewniok B, Weichenthal M, Ehlert U, Rummelein B, Breitbart EW, Rudiger HW. Increased spontaneous formation of micronuclei in cultured fibroblasts of firstdegree relatives of familial melanoma patients. Cancer Genet Cytogenet. 1997;97:106-10. https://doi.org/10.1016/S0165-4608(96)00364-0

Scott D, Barber JB, Levine EL, Burrill W, Roberts SA. Radiation-induced micronucleus induction in lymphocytes identifies a high frequency of radiosensitive cases among breast cancer patients: A test for predisposition? Br J Cancer. 1998;77:614-20. https://doi.org/10.1038/bjc.1998.98

Burril W, Barber JB, Roberts SA, Bulman B, Scott D. Heritability of chromosomal radiosensitivity in breast cancer patients: A pilot study with the lymphocyte micronucleus assay. Int J Radiat Biol. 2000;76:1617-9. https://doi.org/10.1038/sj.bjc.6600628

Bloching M, Hofmann A, Lautenschläger C, Berghaus A, Grummt T. Exfoliative cytology of normal buccal mucosa to predict the relative risk of cancer in the upper aerodigestive tract using the MN-assay. Oral Oncol. 2000;36:550-5. https://doi.org/10.1016/S1368-8375(00)00051-8

Murgia E, Ballardin M, Bonassi S, Rossi AM, Barale R. Validation of micronuclei frequency in peripheral blood lymphocytes as early cancer risk biomarker in a nested case–control study. Mutat Res. 2008;639:27-34. https://doi.org/10.1016/j.mrfmmm.2007.10.010

Bonassi S, Znaor A, Ceppi M, Lando C, Chang WP, Holland N, et al. An increased micronucleus frequency in peripheral blood lymphocytes predicts the risk of cancer in humans. Carcinogenesis. 2007;28:625-31. https://doi.org/10.1093/carcin/bgl177

How to Cite
1.
Barrera LM, Ortiz LD, Grisales H, Rojas M, Camargo M. Flow cytometry in peripheral blood reticulocytes as a marker of chromosome instability in highgrade glioma patients. biomedica [Internet]. 2018 Sep. 1 [cited 2024 May 17];38(3):379-87. Available from: https://revistabiomedica.org/index.php/biomedica/article/view/3882

Some similar items:

Published
2018-09-01
Section
Original articles

Altmetric

Article metrics
Abstract views
Galley vies
PDF Views
HTML views
Other views
Crossref Cited-by logo
QR Code